Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Select Advanced Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07595913
What this trial is testing

ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Early research (Phase 1)Ended earlyNCT05935098
What this trial is testing

BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSolid Tumor
BeiGene 99
Testing effectiveness (Phase 2)UnknownNCT04699643
What this trial is testing

FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
EverNov Medicines (Zhuhai Hengqin) Co., Ltd 80
Testing effectiveness (Phase 2)Ended earlyNCT02341625
What this trial is testing

BMS-986148 in Patients With Select Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 126
Early research (Phase 1)Study completedNCT00343408
What this trial is testing

AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer

Who this might be right for
Colorectal CancerLung Cancer
NCIC Clinical Trials Group 31
Early research (Phase 1)Looking for participantsNCT06597721
What this trial is testing

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorPDACHNSCC
Adcendo ApS 210
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07802418
What this trial is testing

Molecularly Tailored Therapy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Herlev Hospital 1,200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07556848
What this trial is testing

9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Locally Advanced or Metastatic Triple-negative Breast Cancer
Mabwell (Shanghai) Bioscience Co., Ltd. 356
Early research (Phase 1)Active Not RecruitingNCT04188548
What this trial is testing

LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

Who this might be right for
Breast CancerAdvanced Breast CancerMetastatic Breast Cancer+1 more
Eli Lilly and Company 379
Testing effectiveness (Phase 2)Study completedNCT04208958
What this trial is testing

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerMelanomaGastric Cancer+2 more
Vedanta Biosciences, Inc. 56
Not applicableStudy completedNCT01288963
What this trial is testing

IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Beth Israel Deaconess Medical Center 153
Large-scale testing (Phase 3)WithdrawnNCT03529084
What this trial is testing

Phase III Study of Nazartinib (EGF816) Versus Erlotinib/Gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating Mutations

Who this might be right for
Carcinoma, Non-small Cell Lung
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Looking for participantsNCT07518147
What this trial is testing

A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 438
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704
What this trial is testing

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05879822
What this trial is testing

Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

Who this might be right for
Advanced Solid Tumor
Incyte Corporation 73
Large-scale testing (Phase 3)Looking for participantsNCT06072612
What this trial is testing

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Who this might be right for
Breast CancerMetastatic Breast CancerBreast Neoplasm+2 more
BriaCell Therapeutics Corporation 404
Large-scale testing (Phase 3)WithdrawnNCT04943627
What this trial is testing

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)

Who this might be right for
Advanced CancerMetastatic Cervical Cancer
Agenus Inc.
Early research (Phase 1)Looking for participantsNCT07085091
What this trial is testing

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)HNSCCCRC (Colorectal Cancer)+4 more
ALX Oncology Inc. 170
Large-scale testing (Phase 3)Active Not RecruitingNCT06984588
What this trial is testing

Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
TJ Biopharma Co., Ltd. 450
Next Page